Opportunities center on NPPT-coated and blended urea, nitrogen stabilizers, controlled-release products, and climate-smart formulations with emissions verification. Asia-Pacific offers strong ...

For patients with advanced solid tumors harboring specific genetic alterations, the first-in-class synthetic lethal combination of WEE1 inhibitor zedoresertib plus PKMYT1 inhibitor lunresertib ...

What Is It, and Why Does It Matter? Icotyde (icotrokinra) is a once-daily pill for moderate to severe plaque psoriasis. It is for adults and for those 12 years and older who weigh at least 40 ...

FDA authorization covers moderate-to-severe plaque psoriasis in adults and patients aged ≥12 years, expanding systemic options for adolescents. Icotrokinra is characterized as a first-in-class ...

Enlicitide decanoate, an oral proprotein convertase subtilisin–kexin type 9 (PCSK9) inhibitor, was shown to reduce low-density lipoprotein (LDL) cholesterol levels in a phase 2 trial; longer-term data ...

ABSTRACT: In Campeche Mexico, corn production is particularly very important due to its large area of medium and high-yield potential. For any plan production, soil fertility needs to be understood ...

Patients may self-administer Voyxact after receiving proper training on subcutaneous injection technique. The Food and Drug Administration (FDA) has granted accelerated approval to Voyxact ® ...

Lorundrostat, a novel aldosterone synthase inhibitor (ASI), added to SGLT2 inhibitors significantly reduced automated office systolic blood pressure (AOSBP) and albuminuria in patients with chronic ...

The first oral BTK blocker for chronic spontaneous urticaria, Rhapsido offers a more convenient treatment option for patients who still show symptoms after antihistamine treatment. The FDA has ...

Novartis has scored the FDA’s approval for a second BTK inhibitor that’s for a non-cancer indication, teeing off a potential competition with Sanofi down the line. The FDA has blessed Novartis’ ...